Trademark: 87565861
Status Date
Thursday, January 25, 2024
Registration Number
5522690
Registration Date
Tuesday, July 24, 2018
Filing Date
Friday, August 11, 2017
Published for Opposition
Tuesday, February 6, 2018
35 Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; Business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes
45 Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
44 Consulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status
42 Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; Testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes
Jan 25, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 25, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 25, 2024
Case Assigned To Post Registration Paralegal
Aug 2, 2023
Teas Section 8 & 15 Received
Jul 24, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 24, 2018
Registered-Principal Register
Jun 17, 2018
Extension Of Time To Oppose Process - Terminated
Feb 21, 2018
Extension Of Time To Oppose Received
Feb 6, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 6, 2018
Published For Opposition
Jan 17, 2018
Notification Of Notice Of Publication E-Mailed
Dec 30, 2017
Approved For Pub - Principal Register
Dec 30, 2017
Examiner's Amendment Entered
Dec 30, 2017
Notification Of Examiners Amendment E-Mailed
Dec 30, 2017
Examiners Amendment E-Mailed
Dec 30, 2017
Examiners Amendment -Written
Dec 28, 2017
Teas/Email Correspondence Entered
Dec 28, 2017
Correspondence Received In Law Office
Dec 21, 2017
Teas Response To Office Action Received
Nov 15, 2017
Notification Of Non-Final Action E-Mailed
Nov 15, 2017
Non-Final Action E-Mailed
Nov 15, 2017
Non-Final Action Written
Nov 14, 2017
Assigned To Examiner
Aug 31, 2017
Preliminary/Voluntary Amendment - Entered
Aug 31, 2017
Assigned To Lie
Aug 18, 2017
New Application Office Supplied Data Entered
Aug 15, 2017
Teas Voluntary Amendment Received
Aug 15, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
